Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
37 hedge funds and large institutions have $31.6M invested in Global Cord Blood Corporation in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 4 closing their positions.
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
28% more funds holding
Funds holding: 29 → 37 (+8)
13% more capital invested
Capital invested by funds: $28M → $31.6M (+$3.56M)
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$2.41M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.26M |
| 3 |
Renaissance Technologies
New York
|
+$1.21M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.13M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$915K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.98M |
| 2 |
MYAM
Meiji Yasuda Asset Management
Tokyo,
Japan
|
-$930K |
| 3 |
EMR
Errol M. Rudman
|
-$878K |
| 4 |
AR
Advisory Research
Chicago,
Illinois
|
-$219K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$172K |
CO Hedge Fund Activity: Q2 2015 in Review
37 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2015, worth a combined $31.6M — up 13% from $28M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CO positions and 4 closed out — a net gain of 8 holders — while 7 added to existing stakes and 13 trimmed.
The largest buyer was Citigroup, adding an estimated $2.41M. The largest seller was Fidelity Investments, cutting an estimated $7.98M.
- 37 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2015, up from 29 in Q1 2015.
- Funds reported $31.6M of Global Cord Blood Corporation stock for Q2 2015, up 13% quarter-over-quarter.
- 12 funds opened new Global Cord Blood Corporation positions in Q2 2015 and 4 closed out, a net change of +8 holders.
- The largest Global Cord Blood Corporation buyer in Q2 2015 was Citigroup, an estimated $2.41M added.
- The largest Global Cord Blood Corporation seller in Q2 2015 was Fidelity Investments, an estimated $7.98M sold.
Based on aggregated 13F filings for Q2 2015.